グラウコマに対する内視内注射薬:メカニズム,臨床効果,および将来の見通し
Bin Lin1,2,3,4,5,6, Peng Shi1,2,3,4,5,6, Dong-Kan Li1,2,3,4,5,6
1Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Frontiers in pharmacology
|August 29, 2025
まとめ
眼内圧 (IOP) の制御を改善し,従来の治療法の限界に対処します. 未来のイノベーションは 精密で個別化された 緑内障の治療を約束します
科学分野:
- 眼科について
- 薬理学について
- バイオメディカルエンジニアリング
背景:
- 伝統的なグラウコマ治療は 患者の不服従や手術の合併症などの 課題に直面しています
- 内視内注射薬は 緑内障の効果的な管理に 有望な代替手段です
研究 の 目的:
- 緑内障における内視内注射薬のメカニズム,臨床効果,および将来の方向性を検討する.
- 血管内皮成長因子 (抗VEGF) 剤,持続放出剤,手術中の補助剤注射に重点を置く.
主な方法:
- グラウコマの内視内薬投与に関する現在の文献のレビュー.
- 抗VEGF剤,持続放出剤,および手術中の補助療法に関する臨床データの分析
- グラウコマ治療薬の新興技術の探索
主要な成果:
- 抗VEGF薬は新血管性緑内障 (NVG) を効果的に治療し,アフリベルセプトは有意な回復と内血圧の低下を示した.
- 持続放出剤は,長期間 (最大6ヶ月) の内血圧制御を行い,注射頻度を下げます.
- 術内補助注射は,軽微侵襲性緑内障手術 (MIGS) の手術結果を改善する.
結論:
- 静脈内注射は神経血管の活性化を促すことで 緑内障の治療に変化をもたらしています
- 課題には,主疾患依存症と伝達システムの制限が含まれます.
- 遺伝子編集やナノロボティクスのような 新興技術は パーソナライズされた緑内障治療の 可能性を秘めています
関連する概念動画
01:27Open Angle Glaucoma: Treatment
557
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
557
01:28Angle Closure Glaucoma: Treatment
669
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
669
01:25Glaucoma: Overview
745
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
745
01:22Drug Delivery: Miscellaneous Routes
467
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
467